statistiche ricercatore

Continente	#
EU - Europa	1.118
NA - Nord America	968
AS - Asia	448
SA - Sud America	79
Continente sconosciuto - Info sul continente non disponibili	39
AF - Africa	25
OC - Oceania	2
Totale	2.679

Nazione	#
US - Stati Uniti d'America	935
IT - Italia	341
GB - Regno Unito	207
RU - Federazione Russa	205
CN - Cina	133
SG - Singapore	127
IE - Irlanda	101
BR - Brasile	67
SE - Svezia	46
FR - Francia	45
VN - Vietnam	41
KR - Corea	31
DE - Germania	29
HK - Hong Kong	28
FI - Finlandia	27
AT - Austria	25
UA - Ucraina	25
IN - India	24
CA - Canada	19
NL - Olanda	18
BD - Bangladesh	16
ES - Italia	15
BE - Belgio	12
ZA - Sudafrica	11
IQ - Iraq	8
JP - Giappone	8
PK - Pakistan	7
PL - Polonia	7
TR - Turchia	7
EC - Ecuador	6
MX - Messico	6
KE - Kenya	5
RO - Romania	5
AR - Argentina	4
JM - Giamaica	4
CZ - Repubblica Ceca	3
ID - Indonesia	3
AU - Australia	2
CI - Costa d'Avorio	2
NG - Nigeria	2
SA - Arabia Saudita	2
UZ - Uzbekistan	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AO - Angola	1
AZ - Azerbaigian	1
BB - Barbados	1
BG - Bulgaria	1
BH - Bahrain	1
CG - Congo	1
CH - Svizzera	1
CL - Cile	1
CR - Costa Rica	1
DZ - Algeria	1
EG - Egitto	1
EU - Europa	1
GD - Grenada	1
HR - Croazia	1
IR - Iran	1
KH - Cambogia	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
MA - Marocco	1
MD - Moldavia	1
MK - Macedonia	1
NP - Nepal	1
OM - Oman	1
PE - Perù	1
PH - Filippine	1
PR - Porto Rico	1
PS - Palestinian Territory	1
TW - Taiwan	1
Totale	2.641

Nome	#
A novel bioresponsive self-immolative spacer based on aza-quinone methide reactivity for the controlled release of thiols, phenols, amines, sulfonamides or amides	505
Ruthenium-catalyzed synthesis of 5-amino-1,2,3-triazole-4-carboxylates for triazole-based scaffolds: Beyond the Dimroth rearrangement	371
Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation	328
Hedgehog pathway inhibitors of the acylthiourea and acylguanidine class show antitumor activity on colon cancer in vitro and in vivo	324
ErbB2 targeted epigenetic modulation: anti-tumor efficacy of the ADC Trastuzumab-HDACi ST8176AA1	280
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth	267
Histone Deacetylase Inhibitors-based antibody drug conjugates (ADCs) and use in therapy	266
Quinolines and Oxazino-quinoline derivatives as small molecule GLI1 inhibitors identified by virtual screening	183
Fluoromethylcarnitine, a novel inhibitor of trimethylamine levels in trimethylaminuria and trimethylamine N-oxide related disorders	155
Totale	2.679

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	102	0	0	11	5	13	6	4	3	3	12	20	25
2022/2023	191	5	19	23	17	20	35	15	15	23	7	6	6
2023/2024	217	8	11	17	16	6	31	62	11	0	8	17	30
2024/2025	365	28	13	40	26	32	16	29	33	40	16	26	66
2025/2026	993	61	96	92	172	205	34	84	30	58	69	36	56
2026/2027	231	48	180	3	0	0	0	0	0	0	0	0	0
Totale													2.679